Multicenter, randomized, placebo-controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate efficacy and safety of BAY2433334 in patients following an acute non-cardioembolic ischemic stroke (PACIFIC-STROKE).

Project: Research

Project Details

StatusActive
Effective start/end date19/02/21 → 31/12/23

Keywords

  • Ischaemic stroke
  • Neurology
  • Clinical trial